Time and dose effects of mitomycin C on extracellular matrix fibroblasts and proteins

被引:36
作者
Ferguson, B [1 ]
Gray, SD [1 ]
Thibeault, S [1 ]
机构
[1] Univ Utah, Div Otolaryngol Head & Neck Surg, Sch Med, Salt Lake City, UT 84132 USA
关键词
mitomycin C; wound healing; apoptosis; extracellular matrix; collagen fibronectin;
D O I
10.1097/01.mlg.0000150694.08259.80
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: The objective was to determine treatment dose and time-dependent effects of injected mitomycin C on extracellular matrix fibroblasts, collagen, and fibronectin, important mediators in the wound healing response, in a rat cutaneous wound model. Study Design: A prospective, controlled animal study. Methods: Forty rats were injected with three different doses (0.4, 2.3, and 5.0 mg/mL) of mitomycin C at three different wound sites with a fourth wound site receiving saline as a control. The rats were grouped to have their tissue harvested at five different dates ranging from 1 week to 8 weeks. After death, samples from the wound site underwent Western blot analysis for collagen and fibronectin and histological analysis measuring fibroblast apoptosis. Results: Over an 8-week period, collagen and fibronectin significantly decreased and fibroblast apoptosis significantly increased. No correlation was found between the injected dose of mitomycin C and either the extracellular matrix protein concentration or the rate of fibroblast apoptosis. Conclusion: Mitomycin C demonstrated a long-term effect in a wound, inhibiting collagen and fibronectin production and inducing apoptosis. Use of mitomycin C in excess of 0.4 mg/mL did not alter protein concentrations or rate of apoptosis.
引用
收藏
页码:110 / 115
页数:6
相关论文
共 25 条
[1]   Mitomycin-C in the postsurgical ear canal [J].
Banthia, V ;
Selesnick, SH .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2003, 128 (06) :882-886
[2]  
Crowston JG, 2002, INVEST OPHTH VIS SCI, V43, P692
[3]   Can topical mitomycin prevent laryngotracheal stenosis? [J].
Eliashar, R ;
Eliachar, I ;
Esclamado, R ;
Gramlich, T ;
Strome, M .
LARYNGOSCOPE, 1999, 109 (10) :1594-1600
[4]   Preapplication of mitomycin C for enhanced patency of myringotomy [J].
Estrem, SA ;
Baker, TJ .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 122 (03) :346-348
[5]   Use of mitomycin C for maintaining myringotomy patency [J].
Estrem, SA ;
VanLeeuwen, RN .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 122 (01) :8-10
[6]   The effect of mitomycin on extracellular matrix proteins in a rat wound model [J].
Gray, SD ;
Tritle, N ;
Li, WH .
LARYNGOSCOPE, 2003, 113 (02) :237-242
[7]   Topical mitomycin application after laryngotracheal reconstruction - A randomized, double-blind, placebo-controlled trial [J].
Hartnick, CJ ;
Hartley, BEJ ;
Lacy, PD ;
Liu, J ;
Bean, JA ;
Willging, P ;
Myer, CM ;
Cotton, RT .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2001, 127 (10) :1260-1264
[8]   Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts [J].
Hu, D ;
Sires, BS ;
Tong, DC ;
Royack, GA ;
Oda, D .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2000, 16 (02) :119-125
[9]   Sinus surgery: Does mitomycin C reduce stenosis? [J].
Ingrams, DR ;
Volk, MS ;
Biesman, BS ;
Pankratov, MM ;
Shapshay, SM .
LARYNGOSCOPE, 1998, 108 (06) :883-886
[10]  
JAMPEL HD, 1992, OPHTHALMOLOGY, V99, P1471